FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This is an open label, single-arm phase II, multi-institutional trial to evaluate the efficacy and safety of the combination of nab-paclitaxel and FOLFOX (FOLFOX-A) as first line therapy for patients diagnosed with histologically-confirmed advanced gastric/GEJ adenocarcinoma.
Epistemonikos ID: 8d0f2a2031fe1520c9360645f5c0db325248eea1
First added on: May 21, 2024